Диковский Александр Владимирович (RU),Закирова Светлана Анатольевна (RU),Матюшёнок Александр Викторович (BY)
申请号：
RU2014145102
公开号：
RU2014145102A
申请日:
2014.11.10
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
1. A combination comprising: (a) a glycyrrhizin derivative； and (b) a lipid-lowering drug, provided that: the lipid-lowering agent is atorvastatin, and the combination does not contain a molecular complex of atorvastatin and glycyrrhizic acid； and the lipid-lowering agent simvastatin, and the combination does not contain a molecular complex of simvastatin and glycyrrhizic acid. 2. A pharmaceutical composition comprising: (a) a glycyrrhizin derivative； and (b) a lipid-lowering drug； provided that: the lipid-lowering agent is atorvastatin, the composition does not contain a molecular complex of atorvastatin and glycyrrhizic acid； and a lipid-lowering agent simvastatin, the composition does not contain a molecular complex of simvastatin and glycyrrhizic acid. 3. A pharmaceutical composition comprising: (a) a glycyrrhizin derivative； and (b) a lipid-lowering drug； wherein the pharmaceutical composition is a solid pharmaceutical composition. A pharmaceutical composition according to claim 3, characterized in that it is a solid mixture of a glycyrrhizin derivative and a lipid-lowering drug. A kit comprising: (a) a therapeutically effective amount of a glycyrrhizin derivative, and additionally pharmaceutically acceptable carriers or diluents in a first unit dosage form； (b) a therapeutically effective amount of a lipid-lowering drug, and further pharmaceutically acceptable carriers or diluents in a second unit dosage form； and (c) a container for containing said first and second dosage forms. Semi way1. Комбинация, содержащая:(a) глицирризиновое производное； и(b) гиполипидемическое лекарственное средство；при условии, что: гиполипидемическое средство аторвастатин, а комбинация не содержит молекулярный комплекс аторвастатина и глицирризиновой кислоты； и гиполипидемическое средство симвастатин, а комбинация не содержит молекулярный комплекс симвастатина и глицирризиновой кислоты.2. Фармацевтическая композиция, содержащая:(a) глицирризиновое производное； и(b) гиполипидемическо
